A Trial of CRD-4730 in HFrEF

Clinical trial NCT07750873 · RECRUITING

Trial details

NCT number: NCT07750873
Sponsor: Cardurion Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Failure With Reduced Ejection Fraction (HFrEF)

Start date: 2026-07-15
Primary completion: 2028-09-01
Enrollment: 525

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.